Coho Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-34,746
Closed -$2.35M 36
2025
Q1
$2.35M Hold
34,746
0.14% 34
2024
Q4
$1.56M Hold
34,746
0.07% 35
2024
Q3
$2.18M Sell
34,746
-1,739
-5% -$101K 0.08% 31
2024
Q2
$2.15M Sell
36,485
-1,807,992
-98% -$113M 0.08% 32
2024
Q1
$147M Sell
1,844,477
-181,232
-9% -$13.8M 3.61% 11
2023
Q4
$160M Sell
2,025,709
-458,077
-18% -$32.6M 3.72% 10
2023
Q3
$173M Sell
2,483,786
-235,679
-9% -$16.7M 3.69% 11
2023
Q2
$188M Sell
2,719,465
-137,234
-5% -$9.76M 3.41% 13
2023
Q1
$212M Sell
2,856,699
-36,772
-1% -$3.08M 3.67% 13
2022
Q4
$270M Buy
2,893,471
+2,420
+0.1% +$234K 4.57% 2
2022
Q3
$276M Buy
2,891,051
+104,473
+4% +$10.3M 5.18% 1
2022
Q2
$258M Sell
2,786,578
-133,977
-5% -$13.1M 4.81% 3
2022
Q1
$296M Sell
2,920,555
-83,101
-3% -$8.73M 4.87% 2
2021
Q4
$310M Sell
3,003,656
-215,956
-7% -$20M 4.87% 3
2021
Q3
$273M Sell
3,219,612
-71,556
-2% -$5.99M 4.43% 4
2021
Q2
$275M Buy
3,291,168
+19,147
+0.6% +$1.57M 4.3% 5
2021
Q1
$246M Sell
3,272,021
-174
-0% -$12.7K 4% 7
2020
Q4
$223M Buy
3,272,195
+159,078
+5% +$10.3M 3.87% 9
2020
Q3
$182M Buy
3,113,117
+15,311
+0.5% +$953K 3.71% 9
2020
Q2
$201M Buy
3,097,806
+83,208
+3% +$5.24M 4.37% 5
2020
Q1
$179M Sell
3,014,598
-17,706
-0.6% -$1.18M 4.59% 5
2019
Q4
$225M Buy
3,032,304
+461,366
+18% +$32.4M 4.62% 3
2019
Q3
$162M Sell
2,570,938
-90,810
-3% -$5.38M 3.83% 10
2019
Q2
$145M Sell
2,661,748
-53,211
-2% -$2.87M 3.41% 15
2019
Q1
$146M Buy
2,714,959
+161,063
+6% +$9.94M 3.31% 15
2018
Q4
$167M Sell
2,553,896
-3,546
-0.1% -$265K 4.24% 7
2018
Q3
$201M Sell
2,557,442
-58,780
-2% -$4.2M 4.77% 2
2018
Q2
$168M Buy
2,616,222
+81,423
+3% +$5.37M 4.15% 5
2018
Q1
$158M Buy
2,534,799
+497,242
+24% +$35.7M 4.14% 8
2017
Q4
$148M Sell
2,037,557
-116,481
-5% -$8.47M 3.65% 12
2017
Q3
$175M Sell
2,154,038
-148,246
-6% -$11.7M 4.49% 9
2017
Q2
$185M Buy
2,302,284
+476,701
+26% +$37.6M 4.63% 4
2017
Q1
$143M Buy
1,825,583
+381,213
+26% +$30.4M 4.67% 3
2016
Q4
$114M Buy
1,444,370
+18,697
+1% +$1.51M 3.97% 11
2016
Q3
$127M Buy
1,425,673
+236,882
+20% +$22.4M 4.56% 3
2016
Q2
$114M Buy
1,188,791
+102,273
+9% +$10.2M 4.13% 10
2016
Q1
$113M Buy
1,086,518
+300,735
+38% +$29.2M 4.66% 3
2015
Q4
$76.8M Buy
785,783
+15,802
+2% +$1.55M 3.39% 14
2015
Q3
$74.3M Sell
769,981
-64,984
-8% -$6.83M 3.53% 12
2015
Q2
$87.6M Sell
834,965
-6,495
-0.8% -$664K 4.6% 5
2015
Q1
$86.8M Sell
841,460
-153,478
-15% -$15.5M 4.46% 6
2014
Q4
$95.8M Buy
994,938
+49,826
+5% +$4.39M 5.42% 1
2014
Q3
$75.2M Buy
945,112
+35,459
+4% +$2.8M 4.8% 1
2014
Q2
$68.6M Buy
909,653
+40,088
+5% +$3.03M 4.63% 2
2014
Q1
$65.1M Buy
869,565
+49,893
+6% +$3.52M 4.82% 1
2013
Q4
$58.7M Sell
819,672
-15,428
-2% -$991K 4.95% 1
2013
Q3
$47.4M Buy
835,100
+41,273
+5% +$2.46M 4.36% 7
2013
Q2
$45.4M Buy
+793,827
New +$46M 4.53% 4

Other funds holding CVS

Coho Partners's CVS Position: Q2 2025 in Review

Coho Partners sold out of CVS Health (CVS) in Q2 2025, closing a stake of 34,746 shares — an estimated $2.35M sold.

Coho Partners first reported a position in CVS in Q2 2013 and held it in 48 quarters. The position peaked at $310M in Q4 2021. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Coho Partners reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Coho Partners sold 34,746 CVS Health shares in Q2 2025, an estimated $2.35M.
  • Coho Partners first reported a position in CVS Health in Q2 2013 and held it in 48 quarters.
  • Coho Partners's CVS Health position peaked at $310M in Q4 2021.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Coho Partners's 13F filing for Q2 2025, filed 29 Jul 2025.